Features of the clinical manifestation of the cutaneous form of mastocytoma in dogs

dc.contributor.authorMysak, A. R.
dc.contributor.authorIvashkiv, B. B.
dc.date.accessioned2023-11-15T07:02:41Z
dc.date.available2023-11-15T07:02:41Z
dc.date.issued2021
dc.description.abstractAccording to foreign researchers, mastocytoma is one of the most common (7–12 %) skin tumors in dogs. The study aimed to study the features of the clinical manifestation of cutaneous mast cells according to the criteria of the clinical TNM classification. We analyzed 24 cases of cutaneous mastocytoma in dogs during 2016–2020, of diagnostic and therapeutic measures in the Department of Surgery and Clinic of the Small Pets Stepan Gzhytskyi National University of Veterinary Medicine and Biotechnologies Lviv. According to the criteria of the international clinical TNM classification at the time of admission to the clinic in 7 (29.2 %) dogs established stage I of the tumor, 10 (41.7 %) – II, 6 (25 %) – III, and 1 4.1 %) animals – stage IV. Based on cytological evaluation of biopsy material selected from tumors and regional lymph nodes of low-grade mastocytes, 17 (70.8 %) animals were found, and in 7 (29.2 %) cases, neoplasia was characterized as high-grade.uk_UA
dc.identifier.citationЛьвівuk_UA
dc.identifier.urihttps://repository.lvet.edu.ua/handle/123456789/430
dc.language.isoenuk_UA
dc.publisherЛНУВМ та БТ імені С. З. Ґжицькогоuk_UA
dc.subjectdogsuk_UA
dc.subjectmast cell tumoruk_UA
dc.subjectclinical signsuk_UA
dc.subjectcytological examinationuk_UA
dc.subjectmast cell classificationuk_UA
dc.subjectмастоцитомa у собакuk_UA
dc.titleFeatures of the clinical manifestation of the cutaneous form of mastocytoma in dogsuk_UA
dc.typeArticleuk_UA

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
doi 10.32718ujvas4-3.11 Мисак 2021.pdf
Size:
897.76 KB
Format:
Adobe Portable Document Format
Description:
наукова стаття

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: